This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MARGINAL_ZONE_LYMPHOMA_EXALLC for full statistics.
Marginal zone B-cell lymphoma
C3_MARGINAL_ZONE_LYMPHOMA
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
9699
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
197
Check minimum number of events None
197
Include endpoints None
197
Remove individuals based on genotype QC
192
C3_MARGINAL_ZONE_LYMPHOMA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma
based on the number of shared cases.
Broader endpoints:
- Marginal zone B-cell lymphoma (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
- Any event in cancer register
- Malignant neoplasm, wide definition for exclusion
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 192 | 89 | 103 |
| Unadjusted prevalence (%) | 0.05 | 0.04 | 0.06 |
| Mean age at first event (years) | 63.47 | 62.20 | 64.57 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA – Marginal zone B-cell lymphoma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Marginal zone B-cell lymphoma
↥Endpoint not on priority list, no data to show.